THE SCIENCE
The Science Behind Journey Colab
Developing evidence-based synthetically derived psychedelic therapeutics to address the substantial unmet clinical need for effective treatments for addiction, starting with synthetic Mescaline HCl (JOUR-5700) for the treatment of Alcohol Use Disorder (AUD).

The Power of Psychedelics
Why is That Important?


Safe for Clinical Treatment
The Science of Mescaline

Mescaline HCl has a promising safety profile and longer-lasting therapeutic effects.

Journey Colab’s first compound in development is Mescaline HCI (JOUR-5700), a novel potential treatment for AUD


Stronger with Therapy and Community

